RPPA2016: 6th Global Reverse Phase Protein Array Workshop

Reverse Phase Protein Arrays (RPPA) is a well-established technology that allows sensitive and quantitative detection of hundreds of proteins and their post-translational modifications from low amounts of biological samples.

Driven by the desire of many researchers to “look beyond genomics”, RPPA systems are being used by a growing number of academic scientists, biomedical and pharmaceutical companies and CLIA laboratories, for comprehensive analyses of cell culture materials, pre-clinical and clinical tissue as well as fluid samples on the functional protein level.

Methodology and applications of the RPPA technology are constantly evolving. Therefore, pioneers of the technology, experienced users and researchers interested in incorporating the RPPA technology into their own research portfolio will in September gather at the 6th RPPA Global Workshop in Reutlingen, Germany, to discuss the technology’s applications for advancing precision medicine, identifying therapeutic targets, elucidating mechanisms of disease and drug action, discovering and validating biomarkers, as well as new opportunities through emerging technologies.

Free and mutually beneficial exchange of knowledge will be fostered in workshops, presentations, posters and industry showcases. As such, this event will build on the great success of the previous meetings in Houston 2011, Edinburgh 2012, Kobe 2013, Paris 2014, and Virginia 2015.

Join us at RPPA2016!

On behalf of the Organizing Committee,
Thomas Joos, Michael Pawlak, Markus Templin

Please see the meeting program and register via the following link: www.nmi.de/rppa2016
The late-breaking abstract deadline is September 1st, 2016.

http://www.nmi.de/rppa2016

Media Contact

Dr. Nadja Gugeler idw - Informationsdienst Wissenschaft

All latest news from the category: Seminars Workshops

Back to home

Comments (0)

Write a comment

Newest articles

World’s first method

Successful surgery for a rare congenital heart disease “scimitar syndrome”. Scimitar syndrome, a rare congenital heart disease, involves an anomalous pulmonary venous return where the right pulmonary veins return to…

Improving HIV treatment in children and adolescents – the right way!

Globally, around 2.6 million children and adolescents are currently living with HIV, the majority of them in Africa. These young people are much more likely to experience treatment failure than…

Study shows promise for a universal influenza vaccine

OHSU-led research uses innovative vaccine platform to target interior of virus; scientists validate theory using 1918 flu virus. New research led by Oregon Health & Science University reveals a promising…

Partners & Sponsors